135 related articles for article (PubMed ID: 8194510)
1. The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling.
Gilbert ME
Epilepsy Res; 1994 Feb; 17(2):145-56. PubMed ID: 8194510
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of inhibition with perforant path kindling: an NMDA-receptor dependent process.
Gilbert ME
Brain Res; 1991 Nov; 564(1):109-16. PubMed ID: 1838018
[TBL] [Abstract][Full Text] [Related]
3. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats.
Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
Pharmacol Biochem Behav; 1992 Dec; 43(4):1269-72. PubMed ID: 1475311
[TBL] [Abstract][Full Text] [Related]
4. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP.
Morimoto K; Katayama K; Inoue K; Sato K
Pharmacol Biochem Behav; 1991 Dec; 40(4):893-9. PubMed ID: 1840082
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
Sato K; Morimoto K; Okamoto M
Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
[TBL] [Abstract][Full Text] [Related]
6. Kindling-induced potentiation of excitatory and inhibitory inputs to hippocampal dentate granule cells. II. Effects of the NMDA antagonist MK-801.
Robinson GB
Brain Res; 1991 Oct; 562(1):26-33. PubMed ID: 1799870
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic effects of MK-801, a noncompetitive NMDA-receptor antagonist, in the low-frequency kindling model of epilepsy.
Minabe Y; Emori K; Shibata R; Kurachi M
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):755-61. PubMed ID: 1487858
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
9. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
Gilbert ME; Mack CM
Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
[TBL] [Abstract][Full Text] [Related]
10. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid CB1 receptors are involved in antiepileptogenic effect of low frequency electrical stimulation during perforant path kindling in rats.
Mardani P; Oryan S; Sarihi A; Alaei E; Komaki A; Mirnajafi-Zadeh J
Epilepsy Res; 2018 Aug; 144():71-81. PubMed ID: 29800824
[TBL] [Abstract][Full Text] [Related]
12. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
Young NA; Lewis SJ; Vajda FJ; Beart PM
Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute treatment and long-term treatment with MK-801 against amygdaloid kindled seizures in rats.
Yoshida M; Ohkoshi N; Tsuru N
Epilepsy Res; 1997 Mar; 26(3):407-13. PubMed ID: 9127721
[TBL] [Abstract][Full Text] [Related]
14. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
[TBL] [Abstract][Full Text] [Related]
17. The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path-kindled rats.
Sadegh M; Mirnajafi-Zadeh J; Javan M; Fathollahi Y; Mohammad-Zadeh M; Jahanshahi A; Noorbakhsh SM
Neuroscience; 2007 Dec; 150(2):396-403. PubMed ID: 17993248
[TBL] [Abstract][Full Text] [Related]
18. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
Dürmüller N; Craggs M; Meldrum BS
Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
[TBL] [Abstract][Full Text] [Related]
19. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
20. Development of spontaneous seizures over extended electrical kindling. I. Electrographic, behavioral, and transfer kindling correlates.
Michalakis M; Holsinger D; Ikeda-Douglas C; Cammisuli S; Ferbinteanu J; DeSouza C; DeSouza S; Fecteau J; Racine RJ; Milgram NW
Brain Res; 1998 May; 793(1-2):197-211. PubMed ID: 9630628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
